Skip to main content
Clinical Trials/NCT02415920
NCT02415920
Completed
Not Applicable

The Influence of Intranasal Oxytocin on Communication

University of British Columbia1 site in 1 country50 target enrollmentNovember 6, 2017
ConditionsHealthy
InterventionsOxytocinPlacebo

Overview

Phase
Not Applicable
Intervention
Oxytocin
Conditions
Healthy
Sponsor
University of British Columbia
Enrollment
50
Locations
1
Primary Endpoint
Communication Outcomes
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study investigates whether oxytocin, a neuropeptide known for its role in social bonding, influences the outcomes of persuasive communications and several primary evolutionary goals. Participants will be given either oxytocin or placebo on their first visit and then they will receive the other spray during their second visit. At each visit, participants will engage in several psychosocial tasks to assess the role of oxytocin on receptiveness to opposing opinions, navigating the spatial environment, mating and parenting goals. Participants' attitudes and behaviours will be compared across the different conditions.

Detailed Description

Oxytocin is a naturally occurring hormone, commonly known for its role in social approach, bonding, and trust. The present study is designed to investigate whether and how oxytocin may affect communication outcomes--specifically, by influencing trust of people presenting opinions that participants disagree with. Healthy adult volunteers will intranasally administer 24 IU of oxytocin at one visit and placebo (saline) solution at another visit. Participants will then view photos of speakers presenting opinions on various socio-political issues which the participants disagree with. Participants will complete questions about their psychological reactions (e.g., anger, receptiveness) to the opinions presented. After reporting on their receptiveness to the opposing opinions, participants will begin the attentional tasks. In the attentional tasks, participants will be seated in front of a computer while an eyetracker records their eye movements and attentional gaze. First, participants will view two images presented simultaneously at either ends of the computer screen; each image pair will depict a a) baby and a food, b) baby and an attractive opposite sex target, or c) food and an attractive opposite sex target. Next, participants will view a series of images exclusively depicting one attractive opposite-sex target at a time; attentional bias away from faces and towards bodies (indicative of short-term mating interest; Bolmont, Cacioppo, \& Cacioppo, 2014) will be tracked. After each photograph has been viewed for a fixed duration, the participant will answer a question assessing their likelihood of engaging in a one-night stand with the person pictured. After this second part of the task, we will gather saliva samples via passive drool collection. These samples will be later assayed for testosterone. Next participants will complete a measure of visual attention in which they will identify target stimuli (e.g. letters) on a computer screen via keyboard press.

Registry
clinicaltrials.gov
Start Date
November 6, 2017
End Date
December 12, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Frances Chen

Dr. Frances Chen

University of British Columbia

Eligibility Criteria

Inclusion Criteria

  • Healthy adult volunteers

Exclusion Criteria

  • Currently have a diagnosed mental illness or are in psychiatric or psychotherapeutic treatment.
  • Are taking endocrinologically or psychoactive drugs (e.g. psychotropic drugs such as antipsychotics, antidepressants, sedatives, or sleeping pills)
  • Are taking anti-hypertensive drugs or drugs with QTc prolongation
  • Abuse drugs or alcohol
  • Suffer from any significant medical illness, such as heart disease/cardiovascular disease, kidney disease, endocrinological disorders, or neurological disorders.
  • Are not found to be physically healthy after a required prescreen questionnaire created by a doctor
  • Allergic to preservatives (e.g. paragons) found in nasal sprays
  • Pregnant/breastfeeding
  • Are currently involved in other clinical studies in which drugs are administered.

Arms & Interventions

Experimental

These participants will receive 24 international units (IU) of oxytocin via a nasal spray.

Intervention: Oxytocin

Control - Placebo

These participants will receive 24 international units (IU) of a saline solution via a nasal spray.

Intervention: Placebo

Outcomes

Primary Outcomes

Communication Outcomes

Time Frame: 60-90 minutes

Participants will answer a series of questions regarding their reactions (e.g., anger, receptiveness) to the speakers and the opinions presented in the photos. It is expected that when participants receive oxytocin they will be more receptive to opposing opinions compared to when they receive the placebo. Participants may also have differing levels of receptiveness depending on whether the person expressing the opinion comes from their ingroup or outgroup.

Secondary Outcomes

  • Appetite(60-90 minutes)
  • Short vs. Long-Term mating orientation(60-90 minutes)
  • Peripheral narrowing of attention(60-90 minutes)

Study Sites (1)

Loading locations...

Similar Trials